| Features: |
|
HDN-1 is a naturally occurring fungal
epipolythiodioxopiperazine / epipolythiopiperazine-2,5-dione
(ETP) isolated from the Antarctic fungus
Oidiodendron truncatum GW3-13. HDN-1 has demonstrated preclinical
anticancer activity and acts as a direct Hsp90 inhibitor,
binding the C-terminal region of Hsp90α. Hsp90 inhibition by HDN-1 promotes
degradation of multiple oncogenic client proteins, enhances downregulation of
wild-type and mutant EGFR and suppresses tumour-cell proliferation. HDN-1 has
also induced differentiation followed by apoptosis in selected promyelocytic
leukemia cell lines. Its mechanism overlaps with that of the structurally
related ETP chaetocin, which also inhibits Hsp90, but HDN-1 and chaetocin are
chemically distinct compounds and should be maintained as separate products.
HDN-1 should be classified as an experimental natural fungal metabolite
/ epipolythiodioxopiperazine / Hsp90 inhibitor, with current anticancer
evidence predominantly preclinical. |
| Source: |
| Type: |
| MAPK3 (ERK1) ERK proteins are kinases that activate other proteins by adding a phosphate group. An overactivation of these proteins causes the cell cycle to stop. The extracellular signal-regulated kinase (ERK) signaling pathway is a crucial component of the mitogen-activated protein kinase (MAPK) signaling cascade, which plays a significant role in regulating various cellular processes, including proliferation, differentiation, and survival. high levels of phosphorylated ERK (p-ERK) in tumor samples may indicate active ERK signaling and could correlate with aggressive tumor behavior EEk singaling is frequently activated and is often associated with aggressive tumor behavior, treatment resistance, and poor outcomes. |
| 7169- | HDN-1, | CHA, | Identification of epipolythiodioxopiperazines HDN-1 and chaetocin as novel inhibitor of heat shock protein 90 |
| - | in-vitro, | Lung, | H1975 | - | in-vitro, | Lung, | HCC827 | - | in-vitro, | Lung, | A549 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:434 Target#:105 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid